Tumor Budding and E-Cadherin Expression Are Useful Predictors of Nodal Involvement in T1 Esophageal Squamous Cell Carcinoma

被引:5
|
作者
Nakagawa, Yasuo [1 ]
Ohira, Masaichi [1 ]
Kubo, Naoshi [1 ]
Yamashita, Yoshito [2 ]
Sakurai, Katsunobu [1 ]
Toyokawa, Takahiro [1 ]
Tanaka, Hiroaki [1 ]
Muguruma, Kazuya [1 ]
Shibutani, Masatsune [1 ]
Yamazoe, Sadaaki [1 ]
Kimura, Kenjiro [1 ]
Nagahara, Hisashi [1 ]
Amano, Ryosuke [1 ]
Ohtani, Hiroshi [1 ]
Yashiro, Masakazu [1 ]
Maeda, Kiyoshi [1 ]
Hirakawa, Kosei [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan
[2] Osaka City Gen Hosp, Dept Gastroenterol Surg, Osaka, Japan
关键词
T1 Esophageal cancer; tumor budding; E-cadherin; nodal metastasis; GROWTH-FACTOR C; CANCER; METASTASIS; PROGNOSIS; RESECTION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Endoscopic treatment has been increasingly used for T1 esophageal squamous cell carcinoma (ESCC). However, this therapy is sometimes incomplete if the depth of the T1 primary tumor reaches the muscularis mucosae or submucosal layer because these tumors have a relatively high incidence of lymph node metastasis. However, to our knowledge, no previous reports on the prediction of nodal metastasis determined by evaluating primary tumor specimens of patients with ESCC are available. Patients and Methods: A total of 55 patients with T1 ESCC invading as deep as the submucosal layer who underwent curative esophagectomy were examined. We investigated the significance of the immunohistochemical staining of Vascular endothelial growth factor-C (VEGF-C) and E-cadherin in the primary tumor and Tumor budding for prediction of nodal metastasis. Results: Metastasis to the regional lymph nodes was observed in 26 cases (47.3%) in this setting. VEGF-C expression and reduced E-Cadherin expression in the primary tumor was observed in 32 (58.1%) and 38 cases (69.1%), respectively. High-grade tumor budding was observed in 29 cases (52.7%). E-cadherin expression and tumor budding were closely correlated with nodal metastasis (p=0.04 and <0.01 respectively), whereas VEGF-C expression tended to correlate with lymph node metastasis (p=0.06). In addition, high-grade tumor budding was significantly correlated (p<0.01) with reduced E-cadherin expression. The accuracy of tumor budding and E-cadherin expression for nodal metastasis were 67.3% and 65.4% respectively, comparable with the one of lymphatic involvement (63%). Tumor budding (p<0.01), but not E-cadherin and VEGF-C expression, was significantly correlated with poor survival. Conclusion: After the endoscopic treatment, additional therapy, such as surgery or chemoradiotherapy, may be required if reduced E-cadherin expression and high-grade tumor budding are observed in primary tumor specimen.
引用
收藏
页码:5023 / 5029
页数:7
相关论文
共 50 条
  • [21] Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma
    Yoshida, Rintaro
    Morita, Masaru
    Shoji, Fumihiro
    Nakashima, Yuichiro
    Miura, Naoko
    Yoshinaga, Keiji
    Koga, Tadashi
    Tokunaga, Eriko
    Saeki, Hiroshi
    Oki, Eiji
    Oda, Yoshinao
    Maehara, Yoshihiko
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (08) : 2608 - 2614
  • [22] Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer?
    Koyuncuoglu, Meral
    Okyay, Emre
    Saatli, Bahadir
    Olgan, Safak
    Akin, Mustafa
    Saygili, Ugur
    GYNECOLOGIC ONCOLOGY, 2012, 125 (01) : 208 - 213
  • [23] Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma
    Chung, Yvonne
    Lam, Alfred K. Y.
    Luk, John M.
    Law, Simon
    Chan, Kwok-Wah
    Lee, Ping-Yin
    Wong, John
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (11) : 3260 - 3267
  • [24] Slug expression in the E-cadherin preserved tumors is related to prognosis in patients with Esophageal squamous cell carcinoma
    Uchikado, Y
    Natsugoe, S
    Okumura, H
    Setoyama, T
    Matsumoto, M
    Ishigami, S
    Aikou, T
    CLINICAL CANCER RESEARCH, 2005, 11 (03) : 1174 - 1180
  • [25] Altered E-Cadherin Expression and p120 Catenin Localization in Esophageal Squamous Cell Carcinoma
    Yvonne Chung
    Alfred K. Y. Lam
    John M. Luk
    Simon Law
    Kwok-Wah Chan
    Ping-Yin Lee
    John Wong
    Annals of Surgical Oncology, 2007, 14 : 3260 - 3267
  • [26] Syndecan-1 and E-Cadherin Expression in Canine Cutaneous Squamous Cell Carcinoma
    Files, Rita
    Cardoso, Claudia
    Prada, Justina
    Silva, Filipe
    Pires, Isabel
    VETERINARY SCIENCES, 2024, 11 (12)
  • [27] Expression and Significance of RKIP and E-cadherin in Lung Squamous Cell Carcinoma
    Zhu, Chunrong
    Wang, Qingcai
    Xie, Jing
    Shi, Jinfang
    Zhou, Xiumin
    Li, Dapeng
    Xiong, Feng
    Zhang, Lu
    PATHOLOGY & ONCOLOGY RESEARCH, 2013, 19 (01) : 19 - 26
  • [28] Expression of E-Cadherin and Its Implication in Laryngeal Squamous Cell Carcinoma
    Ghosh, Ujjwal
    Ghosh, Suman
    Roy, Anup Kumar
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (50): : 3790 - 3795
  • [29] E-CADHERIN EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BOWIE, GL
    CASLIN, AW
    KINSELLA, AR
    ROLANDS, N
    JONES, AS
    BIRCHMEIER, W
    JOURNAL OF PATHOLOGY, 1992, 168 : A120 - A120
  • [30] E-cadherin expression in squamous cell carcinoma and basal cell tumors in dogs
    Joao, Carolina Franchi
    Tinucci-Costa, Mirela
    Cardilli, Diogo Jose
    Maia Faria, Joice Lara
    Magalhaes, Georgia Mode
    Alessi, Antonio Carlos
    CIENCIA RURAL, 2011, 41 (09): : 1611 - 1616